secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK:        0000882796
Form:       8-K
Filed at:   2022-02-08T23:59:59+00:00
Accession:  0001171843-22-000840
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCryst appoints Machelle Sanders (NC Commerce Sec., ex-Biogen) to board
-------------------------------------------------------------------------

- Appointed Machelle Sanders to board of directors effective Feb 8, 2022.
- Board size increased from 11 to 12; she will serve on Science Committee.
- Sanders is NC Secretary of Commerce and former Biogen operations exec with 30+ years pharma experience.
- She receives automatic grant of 26,667 stock options upon joining and annual 40,000 options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882796/000117184322000840/0001171843-22-000840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882796/000117184322000840/f8k_020822.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-000840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer